眼科治疗性使用抗菌药物现状及其评价模式的建立

Current Situation of Antibiotics Used in Ophthalmology and Establishment of Evaluation Model

通过建立眼科治疗性使用抗菌药物评价模式,以促进眼科治疗性使用抗菌药物的规范性、有效性及安全性。通过调查成都爱尔眼科医院2020年1—12月治疗性使用抗菌药物的现状,以实施临床药师为主导的眼科抗菌药物导向策略(AMS)为基本途径,建立眼科治疗性使用抗菌药物科学化评价方案及其效果评估方法,即抗菌药物评价模式。通过眼科治疗性使用抗菌药物评价模式的建立,将有助于眼科抗菌药物管理工作更加深入和全面。建立眼科抗菌药物使用评价模式,将为其余眼科或眼科医院抗菌药物管理提供参考。

To promote the standardization,effectiveness and safety of ophthalmic therapeutic use of antibacterial drugs by establishing an evaluation model for ophthalmic therapeutic use of antibacterial drugs,by investigating the current situation of therapeutic use of antibiotics in Chengdu Aier Eye Hospital from January to December 2020.With the implementation of the clinical pharmacist-led ophthalmic antimicrobial-oriented strategy(AMS)as the basic approach,a scientific evaluation plan and effect evaluation method for the therapeutic use of antimicrobials in ophthalmology were established,that is,the antimicrobial evaluation model.The establishment of an evaluation model for the therapeutic use of antimicrobials in ophthalmology will help the management of antimicrobials in ophthalmology to be more in-depth and comprehensive.The establishment of an evaluation model for the use of antibiotics in ophthalmology will provide a reference for the management of antibiotics in other ophthalmology or ophthalmology hospitals.